Replies to post #233919 on Biotech Values

[si39]

ABUS 40% of Genevant will be massively diluted.

"Arbutus retains a 40% stake in Genevant, a number that Arbutus said needs to be adjusted for 'significant' dilution due to the convertibles that Genevant has issued since. "
https://rnaitherapeutics.blogspot.com/2020/07/strong-presumption-moderna-covid.html